Published in Prog Clin Biol Res on January 01, 1990
Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma. Am J Pathol (1993) 2.16
Targeting HER2 in breast cancer: overview of long-term experience. Int J Womens Health (2010) 0.80
Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts. Br J Cancer (1999) 0.78
Biological effects of stable overexpression of aromatase in human hormone-dependent breast cancer cells. Br J Cancer (1994) 0.78
Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell (1987) 3.45
Multicolour spectral karyotyping of mouse chromosomes. Nat Genet (1996) 2.90
Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J Biol Chem (2000) 2.47
Morphologic characterization of the pathway of transferrin endocytosis and recycling in human KB cells. Proc Natl Acad Sci U S A (1984) 2.42
c-Myc in breast cancer. Endocr Relat Cancer (2000) 2.32
alpha 2-macroglobulin adsorbed to colloidal gold: a new probe in the study of receptor-mediated endocytosis. J Cell Biol (1981) 2.19
C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance. Br J Cancer (2000) 2.14
Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr Rev (1987) 2.07
Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J Biol Chem (1999) 1.93
Amantadine and dansylcadaverine inhibit vesicular stomatitis virus uptake and receptor-mediated endocytosis of alpha 2-macroglobulin. Proc Natl Acad Sci U S A (1982) 1.76
Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Mol Endocrinol (1987) 1.72
Isolation and characterization of a highly enriched preparation of receptosomes (endosomes) from a human cell line. Proc Natl Acad Sci U S A (1983) 1.68
Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity. J Biol Chem (1999) 1.62
Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines. Proc Natl Acad Sci U S A (1987) 1.61
Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol Endocrinol (1988) 1.59
Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells. Cancer Res (1986) 1.58
Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. Am J Pathol (2001) 1.57
Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor. Eur J Biochem (2001) 1.49
Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis. Oncogene (2008) 1.48
Prelysosomal divergence of transferrin and epidermal growth factor during receptor-mediated endocytosis. Biochemistry (1983) 1.46
Characterization of estrogen responsive transforming activity in human breast cancer cell lines. Cancer Res (1986) 1.44
Matrix metalloproteinase inhibitors. Invest New Drugs (1997) 1.43
Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth. Science (1986) 1.41
Characterization of a novel, membrane-bound, 80-kDa matrix-degrading protease from human breast cancer cells. Monoclonal antibody production, isolation, and localization. J Biol Chem (1997) 1.36
Effect of P-glycoprotein expression on sensitivity to hormones in MCF-7 human breast cancer cells. J Natl Cancer Inst (1992) 1.36
Receptor-mediated endocytosis in cultured fibroblasts: cryptic coated pits and the formation of receptosomes. J Histochem Cytochem (1981) 1.35
Dual regulation of proliferation and apoptosis: c-myc in bitransgenic murine mammary tumor models. Oncogene (2000) 1.29
A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic mice. Genes Chromosomes Cancer (1999) 1.26
Estrogen receptor in adult male rat liver. Endocrinology (1978) 1.26
Oncogene-induced basement membrane invasiveness in human mammary epithelial cells. Clin Exp Metastasis (1994) 1.24
Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene. Proc Natl Acad Sci U S A (1987) 1.22
Induction of epidermal growth factor-related polypeptides by 17 beta-estradiol in MCF-7 human breast cancer cells. Endocrinology (1986) 1.19
Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses. Br J Cancer (2004) 1.19
Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo. Proc Natl Acad Sci U S A (1989) 1.19
Binding and internalization of 125I-alpha 2-macroglobulin by cultured fibroblasts. J Biol Chem (1981) 1.17
Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells. Mol Carcinog (1992) 1.17
Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells. Cancer Res (1993) 1.14
Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions. Crit Rev Oncol Hematol (1992) 1.13
Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice. Cancer Res (1993) 1.12
Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ. Cancer Res (1993) 1.12
Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines. Endocrinology (1995) 1.11
The EGF receptor system as a target for antitumor therapy. Cancer Invest (1991) 1.11
8th San Antonio Breast Cancer Symposium--Plenary lecture. Autocrine and paracrine growth regulation of human breast cancer. Breast Cancer Res Treat (1986) 1.11
Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis. Cell Growth Differ (1995) 1.10
Roles of the matrix metalloproteinases in mammary gland development and cancer. Breast Cancer Res Treat (1998) 1.09
A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo. Mol Endocrinol (1988) 1.08
Induction of ductal morphogenesis and lobular hyperplasia by amphiregulin in the mouse mammary gland. Cell Growth Differ (1996) 1.08
Control of human breast cancer by estrogen, growth factors, and oncogenes. Cancer Treat Res (1988) 1.08
A heparin-binding growth factor secreted from breast cancer cells homologous to a developmentally regulated cytokine. J Biol Chem (1992) 1.08
Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability. Oncogene (1998) 1.07
Growth factors, apoptosis, and survival of mammary epithelial cells. J Mammary Gland Biol Neoplasia (1999) 1.06
ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness. Cancer Res (1989) 1.06
Autocrine and paracrine growth regulation of human breast cancer. J Steroid Biochem (1986) 1.06
Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells. Cancer Res (1989) 1.05
EGF receptor expression, regulation, and function in breast cancer. Breast Cancer Res Treat (1994) 1.03
Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines. J Cell Physiol (1989) 1.03
Expression and ligand binding of alpha 2 beta 1 integrin on breast carcinoma cells. Clin Exp Metastasis (1995) 1.01
The role of cathepsin D in the invasiveness of human breast cancer cells. Cancer Res (1993) 1.01
Internalization of alpha 2 macroglobulin in receptosomes. Studies with monovalent electron microscopic markers. Exp Cell Res (1981) 0.99
Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness. Exp Cell Res (1999) 0.98
Transforming growth factor beta 1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Cancer Res (1991) 0.98
Defining a role for c-Myc in breast tumorigenesis. Breast Cancer Res Treat (1997) 0.97
Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis. Oncogene (2000) 0.97
Tyrosine kinase receptor--nuclear protooncogene interactions in breast cancer. Cancer Treat Res (1992) 0.97
Structure-based approach for the discovery of bis-benzamidines as novel inhibitors of matriptase. J Med Chem (2001) 0.97
Growth regulation of human breast carcinoma occurs through regulated growth factor secretion. J Cell Biochem (1987) 0.96
The effects of a constitutive expression of transforming growth factor-alpha on the growth of MCF-7 human breast cancer cells in vitro and in vivo. Mol Endocrinol (1989) 0.95
Synthesis and evaluation of the sunflower derived trypsin inhibitor as a potent inhibitor of the type II transmembrane serine protease, matriptase. Bioorg Med Chem Lett (2001) 0.95
Post-transcriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-O-tetradecanoylphorbol-13-acetate. J Biol Chem (1991) 0.95
Differential alteration of stem and other cell populations in ducts and lobules of TGFalpha and c-Myc transgenic mouse mammary epithelium. Tissue Cell (2005) 0.95
Expression of the transforming growth factor-alpha/epidermal growth factor receptor pathway in normal human breast epithelial cells. Endocrinology (1990) 0.94
Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens. Cancer Res (1988) 0.94
c-Myc alters the DNA damage-induced G2/M arrest in human mammary epithelial cells. Br J Cancer (2003) 0.94
Transforming growth factor alpha production and epidermal growth factor receptor expression in normal and oncogene transformed human mammary epithelial cells. Mol Endocrinol (1989) 0.94
Mechanisms of growth control in normal and malignant breast epithelium. Recent Prog Horm Res (1989) 0.93
The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice. Clin Cancer Res (1996) 0.93
Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells. Mol Endocrinol (1988) 0.93
The process of malignant progression in human breast cancer. Ann Oncol (1990) 0.93
Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis. Oncogene (1996) 0.92
Tissue culture conditions determine the effects of estrogen and growth factors on the anchorage independent growth of human breast cancer cell lines. J Steroid Biochem Mol Biol (1991) 0.91
Ultrastructure of the putative stem cell niche in rat mammary epithelium. Tissue Cell (2003) 0.91
Receptor-mediated endocytosis of alpha 2-macroglobulin: inhibition by ionophores and stimulation by Na+ and HCO3(-). Ann N Y Acad Sci (1982) 0.91
Reversible and irreversible inhibitors of clustering of alpha 2M in clathrin-coated pits on the surface of fibroblasts. Exp Cell Res (1982) 0.90
Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors. Clin Cancer Res (1998) 0.89
Induction of transforming growth factor beta by the antiestrogens droloxifene, tamoxifen, and toremifene in MCF-7 cells. Am J Clin Oncol (1991) 0.88
Endocrine therapy of human breast cancer cells: the role of secreted polypeptide growth factors. Cancer Cells (1989) 0.88
The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells. Biochem Biophys Res Commun (1989) 0.88
Stromal influences on transformation of human mammary epithelial cells overexpressing c-myc and SV40T. J Cell Physiol (1990) 0.87
Hormonal control of human breast cancer cell lines. Cancer Surv (1986) 0.87
Binding and internalization of alpha 2-microglobulin by cultured fibroblasts. Effects of monovalent ionophores. Exp Cell Res (1982) 0.86
Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc. Oncogene (2001) 0.85
Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc. Clin Cancer Res (1998) 0.85
An unusual sex steroid-binding protein in mature male rat liver cytosol. Endocrinology (1978) 0.85
Detection of amphiregulin and Cripto-1 in mammary tumors from transgenic mice. Mol Carcinog (1996) 0.85
Antiestrogen resistance in ER positive breast cancer cells. Breast Cancer Res Treat (1994) 0.84
Growth factor and sex steroid interactions in breast cancer. J Mammary Gland Biol Neoplasia (1996) 0.84
Growth regulatory peptide production by human breast carcinoma cells. J Steroid Biochem (1988) 0.83
17 Alpha-ethinyl estradiol is more potent than estradiol in receptor interactions with isolated hepatic parenchymal cells. Endocrinology (1981) 0.83
Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice. Br J Cancer (2004) 0.83
Progestins and antiprogestins in mammary tumour growth and metastasis. Hum Reprod (1994) 0.83